single-cell omics

Etiome is a biotechnology company developing and deploying Biostaged Medicines, stage-specific therapies delivered to the right patient population at the right time. By building detailed models of molecular changes over the course of disease and applying single-cell omics and artificial intelligence, Etiome uncovers hidden patterns of disease progression to identify disease-modifying targets and biomarkers. Founded in 2021, originating from Flagship Pioneering's Preemptive Health and Medicine initiative.

Read more

Artificial Intelligencebiomarker discoverycomputational biologydrug discoverymachine learningtarget discovery

Fulcrum Genomics is a bioinformatics consulting firm founded by computational biologists from the Broad Institute. Its founders authored Picard and htsjdk, helped define the SAM/BAM and VCF specs, and maintain fgbio. The team of fourteen PhD-level scientists and engineers provides genomic analysis and production-grade pipeline engineering for wet-lab scientists across diagnostics, therapeutics, sequencing, and clinical genomics.

Read more

bioinformatics consultingCLIA/CAP validationcustom pipeline developmentgenome editing analysislong-read sequencing validationsoftware engineeringUMI-based analysis